Clinical Biomarker Analysis Service

ProQinase has established several biomarker assays to determine various biomarker proteins in serum or plasma samples derived from clinical trials. This service includes support for the design of study protocols, the selection of suitable biomarkers and the scheduling of sample collection. We also provide advice regarding sample processing and logistics.

Plasma and serum biomarkers are quantified by means of sandwich ELISAs. The focus of ProQinase's clinical biomarker analysis service is on biomarker proteins which are related to angiogenesis. These biomarker assays complement ProQinase's expertise in the angiogenesis research area.

A biomarker assay is available for the following serum or plasma biomarker proteins:

Biomarker

Type of Biomarker

Preferred Sample Type

Serum

EDTA/Platelet- poor Plasma

ANG1

Ligand

-

X

ANG2

Ligand

X

X

bFGF

Ligand

-

X

HGF

Ligand

X

X

IL-8

Ligand

X

-

PlGF

Ligand

X

X

VEGF-A

Ligand

-

X

VEGF-C

Ligand

-

X

sEGFR

soluble receptor domain

X

X

sE-Selectin

soluble receptor domain

X

-

sSCFR/c-KIT

soluble receptor domain

-

X

sTIE2

soluble receptor domain

X

-

sVEGF-R1

soluble receptor domain

X

X

sVEGF-R2

soluble receptor domain

X

X

sVEGF-R3

soluble receptor domain

X

X

Additional biomarker assays are available on request (including mouse biomarkers).

Please inquire for more specific information about our clinical biomarker service and for the collection & processing guidelines of serum and plasma samples.

 

back

 
clinical biomarker, biomarker assays, serum biomarker, plasma biomarker
Imprint | Copyright 2002-2010 ProQinase GmbH. All rights reserved.